ICON

ICON plc is a global healthcare intelligence and clinical research organization (CRO) based in Dublin, Ireland. Founded in 1990, the company employs around 41,900 people across 106 locations in 55 countries. ICON specializes in clinical development and commercialization services for pharmaceutical, biotechnology, and medical device sectors, as well as government and public health organizations. The company offers a wide range of services throughout the clinical development lifecycle, including clinical trial management, consulting on drug and device strategies, medical imaging, laboratory services, late-phase research, and regulatory consultancy. ICON has expanded its capabilities through strategic acquisitions, enhancing its expertise in healthcare intelligence and clinical trial services. With a commitment to quality and social responsibility, ICON aims to exceed regulatory standards and positively impact communities and the environment. In 2024, ICON reported revenues of approximately $8.28 billion, solidifying its position as a leading CRO in the industry.